White & Case, O'Melveny Lead $520M Progenics Buy
Diagnostic imaging products manufacturer Lantheus, led by White & Case, said Wednesday it will snap up oncology-focused Progenics, advised by O'Melveny & Myers, for roughly $519.6 million in stock....To view the full article, register now.
Already a subscriber? Click here to view full article